Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-15-000362

Options or other derivatives

  • SVP - Novus Biologicals acquired 10,875 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Eansor Norman David · SVP - Novus Biologicals

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2015-08-07 Grant or award : show line 1 in the form Stock Option (Right to Buy) +9,375 $108.49 2022-08-07 9,375 9,375 D
2015-08-07 Grant or award : show line 2 in the form Restricted Stock Units +1,500 1,500 1,500 D
Loading xslF345X03/edgar.xml…